ESCO Technologies (ESE) Q1 2025 earnings summary

Executive summary

• Q1 2025 sales grew 13.2% year-over-year to $247 million, all organic, with all segments posting revenue and EBIT growth.

• Adjusted EPS rose 41% to $1.07, and GAAP EPS increased 54% to $0.91, both above prior guidance.

• Record backlog reached $907 million, up 3% from prior quarter, with a book-to-bill ratio of 1.11.

• Raised full-year Adjusted EPS guidance to $5.55–$5.75, reflecting confidence in continued growth.

• Pending $550 million SM&P acquisition and ongoing strategic review of VACCO may impact future results.

Financial highlights

• Net sales: $247.0 million (Q1 2025) vs $218.3 million (Q1 2024), up 13.2%.

• Adjusted EBIT margin improved to 15.3% from 12.8% year-over-year; Adjusted EBITDA margin expanded to 18.8%.

• Operating cash flow was $34.2 million, up from $8.7 million year-over-year; free cash flow improved significantly.

• Capital expenditures decreased to $5.2 million from $7.8 million year-over-year.

• Debt-to-EBITDA leverage ratio dropped to 0.4x.

Outlook and guidance

• Full-year Adjusted EPS guidance raised to $5.55–$5.75, up $0.25 from previous guidance, representing 16–21% growth over FY24.

• Sales growth guidance remains at 6%–8% for the year, or $1.09–$1.11 billion.

• Q2 2025 Adjusted EPS guidance set at $1.20–$1.30, up 10–19% year-over-year.

• Guidance excludes impacts from the SM&P acquisition and VACCO review.

• Management expects strong liquidity and capital resources to support operations and capital needs.